Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Exploring the antidiabetic potential of Rhamnus alaternus: A combined in vitro, in vivo and in silico approach

Lookup NU author(s): Dr Jie ZhangORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Diabetes mellitus is a complex metabolic disorder associated with oxidative stress, inflammation, and progressive organ damage. This study investigated the phytochemical composition, antioxidant potential, antidiabetic activity, and possible molecular mechanisms of a methanolic extract of Rhamnus alaternus leaves (RME) using in vitro, in vivo, histopathological, and in silico approaches. Phytochemical analysis revealed high levels of total phenolics (223.25 mg GAE/g extract) and flavonoids (92.37 mg QE/g), along with strong antioxidant activity measured by DPPH radical scavenging (IC50 = 184.80 μg/mL) and lipid peroxidation inhibition (IC50 = 29.03 μg/mL). HPLC/UV profiling identified sixteen phenolic compounds, mainly flavonoids, including quercetin (2.56 mg/g), rutin (2.13 mg/g), and kaempferol (1.95 mg/g). In vivo experiments showed that alloxan-induced diabetic rats developed severe hyperglycemia (4.22 g/L), dyslipidemia, hepatic and renal dysfunction, oxidative stress, and inflammatory responses. Oral administration of RME (200 mg/kg for 90 days) significantly reduced blood glucose levels by approximately 58%, improved lipid parameters, restored protein and albumin levels, and normalized hepatic (AST, ALT, ALP, γ-GT) and renal (urea, creatinine, uric acid) biomarkers. RME also reduced malondialdehyde levels and restored antioxidant enzymes (SOD, CAT, GPx) in liver and kidney tissues, while significantly decreasing tumor necrosis factor-α and prostaglandin E2 levels. Histopathological analysis confirmed protective effects on liver, pancreas, and kidney tissues. Molecular docking suggested strong multi-target interactions of flavonoids, particularly rutin and chrysin, with α-glucosidase, dipeptidyl peptidase-4, Glucokinase, and PPAR-γ. Overall, RME exhibited significant antidiabetic, antioxidant, anti-inflammatory, and organ-protective effects, highlighting its potential as a natural therapeutic candidate for diabetes management.


Publication metadata

Author(s): Reffas AI, Boufadi MY, Moulai-Hacene F, Keddari S, Mekraf S, Tou A, Demmouche A, Moussa H, Nasrallah N, Elfalleh W, Bendif H, Ali MAM, Rahman S, Zhang J, Amrane A, Tahraoui H

Publication type: Article

Publication status: Published

Journal: Food Bioscience

Year: 2026

Volume: 80

Print publication date: 01/06/2026

Online publication date: 30/04/2026

Acceptance date: 29/04/2026

ISSN (print): 2212-4292

ISSN (electronic): 2212-4306

Publisher: Elsevier Ltd

URL: https://doi.org/10.1016/j.fbio.2026.109010

DOI: 10.1016/j.fbio.2026.109010


Altmetrics

Altmetrics provided by Altmetric


Share